Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: J Sex Med. 2016 Sep;13(9):1333–1346. doi: 10.1016/j.jsxm.2016.06.014

Table 4.

Baseline Characteristics of Female Participants with Chronic Kidney Disease According to Sexual Activity Status

Characteristic Overall
n=198		 Sexually
Active
n=42		 Not Sexually
Active
n=156		 p-value*
Demographic
  Age (yrs)a 70.1(9.6) 65.1 (9.4) 71.5 (9.2) 0.0001
  Race/Ethnicity 0.57
Whiteb 57.1 64.3 55.1
African-Americanb 36.9 31.0 38.5
Otherb 6.1 4.8 6.4
  Educationb 0.46
Less than High Schoolb 14.1 9.5 15.4
High School Graduate/GEDb 22.7 16.7 24.4
Post High Schoolb 33.8 38.1 32.7
College Degreeb 29.3 35.7 27.6
  Lives with Othersb 65.2 85.7 59.6 0.0016
Behavioral Risk Factors
  Smoking (pack-yrs)§ 1.0 (0 – 20) 1.5 (0 – 19) 0 (0 – 10) 0.046
  Alcohol (drinks/typical week)§ 1.0 (0 – 2) 1.0 (0 – 1) 0 (0 – 1) 0.004
  Moderate-intensity physical activity 0.25
0–60 minutes per dayb 78.3 69.1 80.8
1–4 hours per dayb 15.7 21.4 14.1
4 or more hours per dayb 6.1 9.5 5.1
Systolic Blood Pressure 0.29
  < 140 mmHgb 54.0 61.9 51.9
  140 – 160 mmHgb 31.8 31.0 32.2
  >160 mmHgb 14.1 7.1 16.0
Antihypertension Medications
  Use of beta-blockersb 38.9 40.5 38.5 0.81
  Use of diureticsb 45.5 28.6 50.0 0.013
  Use of calcium channel blockersb 36.4 38.1 35.9 0.79
  Use of angiotensin receptor
      converting enzyme inhibitorsb 		36.4 33.3 37.2 0.65
  Use of angiotensin receptor blockersb 23.7 28.6 22.4 0.41
  Total number of antihypertensive
      medications a 		2.05 (1.0) 1.9 (1.0) 2.1 (1.0) 0.37
Cardiometabolic and Psychosocial Variables
  Glucose (mg/dL) a 95.6 (13.5) 94.8 (12.0) 95.8 (13.9) 0.67
  Total Cholesterol (mg/dL) a 199.9 (37.9) 199.9 (34.4) 199.9 (38.9) 0.99
  Any anti-cholesterol medicationb 47.0 52.4 45.5 0.43
  Any menopausal hormonesb 10.1 16.7 8.3 0.15
  Any antidepressant medicationb 19.7 19.1 19.9 0.91
  BMI (kg/m2) a 29.7 (6.9) 29.3 (5.5) 29 8 (7.3) 0.62
  eGFR (mL/min/1.73 m2) a 46.5 (10.6) 47.4 (11.1) 46.2 (10.5) 0.52
  CVD Family Historyb 33.7
  MoCA Score a, c 22.6 (4.8) 23.8 (3.3) 22.3 (5.1) 0.026
  PHQ-9 Total Score §, d 2.0 (0 – 4)) 2.0 (0 – 6) 2.0 (0 – 6) 0.67
  Number of Physical Comorbidities a, d 5.3 (2.7) 4.9 (2.1) 5.5 (2.9) 0.16
a

Data presented as mean(standard deviation);

§

Data presented as median (Interquartile range)

b

data presented as %

c

Higher scores indicate better function

d

Higher scores indicate poorer function

*

p-value from Chi Square test for categorical variables and Student’s t-test for continuous variables significant (p<0.05) values presented in bold